An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis
NCT ID: NCT01609049
Last Updated: 2017-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1496 participants
OBSERVATIONAL
2011-12-07
2015-06-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
NCT00304551
Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis
NCT00301509
Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)
NCT02106156
Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients
NCT00526448
Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and Ribavirin
NCT01634919
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with Chronic Hepatitis C
Naive and previously treated participants who received peginterferon alfa-2a in combination with ribavirin as per local labeling requirements.
Peginterferon alfa-2a
Administration of treatment will be according to local recommendation under local labeling.
Ribavirin
Ribavirin tablets twice daily orally will be administered depending on body weight, according summary product characteristics and prescribing of ribavirin in real clinical practice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peginterferon alfa-2a
Administration of treatment will be according to local recommendation under local labeling.
Ribavirin
Ribavirin tablets twice daily orally will be administered depending on body weight, according summary product characteristics and prescribing of ribavirin in real clinical practice.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Compensated liver cirrhosis (Child-Pugh Class A) included
* Initiating combined therapy with peginterferon alfa-2a and ribavirin
Exclusion Criteria
* Contraindications for combined therapy according to actual prescribing information
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Altay Region Aids Center
Barnaul, , Russia
Barnaul City Hospital #5; Therapy
Barnaul, , Russia
Chelyabinsk State Medical Academy; Infectious Diseases
Chelyabinsk, , Russia
Chita State Medical Academy
Chita, , Russia
Irkutsk Regional Consulting and Diagnostic Clinical Center; Regional Center of Reumatolodic Deasise
Irkutsk, , Russia
Kaluga regional AIDS center
Kaluga, , Russia
Kazan State Medical University
Kazan', , Russia
Kemerovo City Infectious Clinical Hospital; Infectious
Kemerovo, , Russia
Khabarovsk-1 Road Clinical Hospital; Gastroenterology
Khabarovsk, , Russia
Aids Center; Infectious
Khabarovsk, , Russia
Kirov Region Aids-Center; Infectious
Kirov, , Russia
Clinical Center for the Prevention and Control of AIDS and Infectious Diseases
Krasnodar, , Russia
Specialized clinical infectious hospital
Krasnodar, , Russia
Region Cinical Hospital; Gastroenterology
Krasnoyarsk, , Russia
Krasnoyarsk Region Aids Center; Hepatology
Krasnoyarsk, , Russia
Lipetsk Region Aids Center
Lipetsk, , Russia
The scientific-research institute of epidemiology
Moscow, , Russia
Central Medicosanitary Dept #165
Moscow, , Russia
Russian Uni of People'S Friendship, Med. Faculty; City Clinical Hospital No 64, Internal Diseases
Moscow, , Russia
Central Clinical Hospital of RAS ; HEPATOLOGY
Moscow, , Russia
FGBU "Polyclinic #1 Administration President RF
Moscow, , Russia
I.M. Sechenov First Moscow State Medical University, The V.H.Vasilenko Clinic
Moscow, , Russia
I.M. Sechenov First Moscow State Medical University: The E.M. Tareyev Clinic
Moscow, , Russia
Hosital of Infectious Disease #1
Moscow, , Russia
State Medical Stomatological Uni ; Infectious
Moscow, , Russia
Russian Medical Academy of Postgraduate Education on Botkin S.P. ; City Clinical Hospital
Moscow, , Russia
City Hospital # 24; Hepatology
Moscow, , Russia
Clinical hospital Centrosouz
Moscow, , Russia
3-D Military Clinical Hospital
Moscow, , Russia
Medelitconsulting; Medical
Moscow, , Russia
AIDS Center
Nizniy Novgorod, , Russia
Infections Deseases Hospital #1
Novosibirsk, , Russia
Baranov Republican Hospital
Petrozavodsk, , Russia
City Hospital #1 After Semashko N.A.
Rostov-on-Don, , Russia
Rostov State Medical Uni ; Infectious Diseases
Rostov-on-Don, , Russia
City Hospital #2; Nefrology
Rostov-on-Don, , Russia
Ryazan State Medical University Named after I.P.Pavlov
Ryazan, , Russia
S.P. Botkin Clinical Infectious Disease Hospital
Saint Petersburg, , Russia
Military Medical Academy; Infectious Deseases
Saint Petersburg, , Russia
City polyclinic №107
Saint Petersburg, , Russia
Research institute of influenza named after I.I.Mechnikov
Saint Petersburg, , Russia
St. Petersburg Aids Center; Haepatology
Saint Petersburg, , Russia
Samara State Medical Uni ; Hepatogastroenterology
Samara, , Russia
MC Gepatolog
Samara, , Russia
City Clinical Hospital №2; Infectional diseases department
Saratov, , Russia
Saratov Region Aids Center; Infectious Diseases
Saratov, , Russia
Stavropol State Medical Academy
Stavropol, , Russia
Consulting diagnostic center
Tyumen, , Russia
State Medical Uni of Republic Bashkortostan; Infection Diseases
Ufa, , Russia
Vladivostok state medical university
Vladivostok, , Russia
MUZ City Clinical Infectional Hospital
Vladivostok, , Russia
Volgograd Regional Aids Center For Aids and Infectious Diseases T Volgograd
Volgograd, , Russia
Regional Clinical Hospital of Infectious Diseases
Voronezh, , Russia
Yakutsk City Hospital
Yakutsk, , Russia
Ekaterinburg Regional Hospital #1; Gastroenterology
Yekaterinburg, , Russia
National Center for Prevention and Control of AIDS and Infectious Diseases
Yoshkar-Ola, , Russia
Dongnam Inst.of Radiological & Medical Sciences
Busan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML27851
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.